ELVN logo

Enliven Therapeutics, Inc. (ELVN) Operating expenses

annual operating expenses:

$104.55M+$21.02M(+25.17%)
December 31, 2024

Summary

  • As of today (July 11, 2025), ELVN annual total operating expenses is $104.55 million, with the most recent change of +$21.02 million (+25.17%) on December 31, 2024.
  • During the last 3 years, ELVN annual operating expenses has risen by +$79.79 million (+322.24%).
  • ELVN annual operating expenses is now at all-time high.

Performance

ELVN Operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVNincome statement metrics

quarterly operating expenses:

$31.69M+$4.80M(+17.84%)
March 31, 2025

Summary

  • As of today (July 11, 2025), ELVN quarterly total operating expenses is $31.69 million, with the most recent change of +$4.80 million (+17.84%) on March 31, 2025.
  • Over the past year, ELVN quarterly operating expenses has increased by +$5.71 million (+21.96%).
  • ELVN quarterly operating expenses is now at all-time high.

Performance

ELVN quarterly operating expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVNincome statement metrics

Operating expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

ELVN Operating expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+25.2%+22.0%
3 y3 years+322.2%+265.2%
5 y5 years+1022.1%+277.5%

ELVN Operating expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+322.2%at high+251.5%
5 y5-yearat high+1022.1%at high+277.5%
alltimeall timeat high+1022.1%at high+277.5%

ELVN Operating expenses History

DateAnnualQuarterly
Mar 2025
-
$31.69M(+17.8%)
Dec 2024
$104.55M(+25.2%)
$26.90M(-0.6%)
Sep 2024
-
$27.07M(+10.0%)
Jun 2024
-
$24.60M(-5.3%)
Mar 2024
-
$25.99M(+14.3%)
Dec 2023
$83.53M
$22.73M(-6.3%)
Sep 2023
-
$24.25M(+20.4%)
Jun 2023
-
$20.13M(+22.6%)
DateAnnualQuarterly
Mar 2023
-
$16.42M(+61.5%)
Dec 2022
$38.79M(+56.7%)
$10.16M(-7.1%)
Sep 2022
-
$10.93M(+21.3%)
Jun 2022
-
$9.02M(+3.9%)
Mar 2022
-
$8.68M(+3.4%)
Dec 2021
$24.76M(+165.7%)
-
Dec 2021
-
$8.39M
Dec 2020
$9.32M
-

FAQ

  • What is Enliven Therapeutics, Inc. annual total operating expenses?
  • What is the all time high annual operating expenses for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. annual operating expenses year-on-year change?
  • What is Enliven Therapeutics, Inc. quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. quarterly operating expenses year-on-year change?

What is Enliven Therapeutics, Inc. annual total operating expenses?

The current annual operating expenses of ELVN is $104.55M

What is the all time high annual operating expenses for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high annual total operating expenses is $104.55M

What is Enliven Therapeutics, Inc. annual operating expenses year-on-year change?

Over the past year, ELVN annual total operating expenses has changed by +$21.02M (+25.17%)

What is Enliven Therapeutics, Inc. quarterly total operating expenses?

The current quarterly operating expenses of ELVN is $31.69M

What is the all time high quarterly operating expenses for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high quarterly total operating expenses is $31.69M

What is Enliven Therapeutics, Inc. quarterly operating expenses year-on-year change?

Over the past year, ELVN quarterly total operating expenses has changed by +$5.71M (+21.96%)
On this page